Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001213900-26-048326
- form_type
- 8-K
- ticker
- AMST
- cik
- 0001807166
- company_name
- Amesite Inc.
- filed_at
- 2026-04-28T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:32.950699+00:00
- generated_at
- 2026-05-15T03:05:21.385697+00:00
- sec_items
- ["1.01", "3.02", "8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.75
- calibrated_materiality_score
- 0.75
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001213900-26-048326
- json_url
- https://secwatch.observer/filing/0001213900-26-048326.json
- markdown_url
- https://secwatch.observer/filing/0001213900-26-048326.md
- text_url
- https://secwatch.observer/filing/0001213900-26-048326.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1807166/000121390026048326/0001213900-26-048326-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1807166/000121390026048326/ea0287970-8k_amesite.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
138ff7f2b47a3111557e4177a84abc019cee0254
Amesite Inc. entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D, its Chairman and CEO, and George Parmer, a member of its board of directors valued at aggregate gross proceeds from the Insider-Led Private Placement are expected to be approximately $60 (effective 2026-04-27).
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
3272edb40708a88053264c2e511e038c8c184af9
Amesite Inc. entered into RD Purchase Agreement with certain institutional investors valued at aggregate gross proceeds from Registered Direct and Private Placement are expected to be approximate (effective 2026-04-27).
On April 27, 2026, Amesite Inc. (the “Company”) entered into a securities purchase agreement (the “RD Purchase Agreement”) with certain institutional investors
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
441a7d30ec3aa0cdaebcbfa65764617348c00ce0
Amesite Inc. entered into Registration Rights Agreement with certain institutional investors (effective 2026-04-27).
the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with certain institutional investors
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
b147d2e8d0a37a23b72bd5fece9d604a3515f318
Amesite Inc. entered into PIPE Purchase Agreement with certain institutional investors valued at aggregate gross proceeds from Registered Direct and Private Placement are expected to be approximate (effective 2026-04-27).
the Company entered into a securities purchase agreement (the “PIPE Purchase Agreement” and together with the RD Purchase Agreement, the “Purchase Agreements”) with certain institutional investors
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
Comparable filings
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 8.01, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
A Share Rights Agreement, dated May 26, 2026, by and between the Company and Odyssey Transfer and Trust Company, as rights agent
Filing page
SEC filing
SAGU
Shreya Acquisition Group closes $110M IPO, 11M units at $10 each on NYSE
Shreya Acquisition Group
May 11, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 8.01, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
Private Units Subscription Agreement, dated May 6, 2026, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 and incorporated herein by reference
Filing page
SEC filing
CLRB
Cellectar raises ~$35M via stock/warrant offering; reports positive 12-mo Phase 2b WM data
Cellectar Biosciences, Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 8.01, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
pursuant to an additional securities purchase agreement with certain members of the executive management team of the Company (the “Management Purchase Agreement”
Filing page
SEC filing
KRMN
Selling stockholders price upsized secondary offering of 14M shares at $61/share for ~$854M gross proceeds
Karman Holdings Inc.
June 1, 2026, 5:28 PM ET
other_material
Items 1.01, 7.01, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 8.01, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
On May 28, 2026, Karman Holdings Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with the persons named in Schedule II thereto (the “Selling Stockholders”) and Citigroup Global Markets Inc. and Evercore Group L.L.C., as the underwriters (the “Underwriters”), pursuant to which the Selling Stockholders agreed to sell 14,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at a public offering price of $61.00 per share (the “Offering Price”), less underwriting discounts and commissions (the “Offering”).
Filing page
SEC filing
XRN
Chiron Real Estate enters $100M preferred equity deal with Maewyn XRN LP
Chiron Real Estate Inc.
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
In connection with the Private Placement, on May 6, 2026, the Company and the Purchasers entered an Investor Rights Agreement.
Filing page
SEC filing
AREB
American Rebel exchanges $1.77M preferred & note for ~5.97M common shares to Streeterville
AMERICAN REBEL HOLDINGS INC
May 8, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.02, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
Streeterville
Series E Preferred Exchange Agreements On
April 30, 2026, the Company entered into three Exchange Agreements (the “Exchanges”) with Streeterville.
Filing page
SEC filing
ETR
Entergy sells 19.2M shares via forward sale at $110.74, raising ~$2.13B
ENTERGY CORP /DE/
May 7, 2026, 7:59 PM ET
other_material
Items 1.01, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 8.01, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
In connection with the Forward Sale Agreements, the Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with Wells Fargo Securities, LLC, Citigroup Global Markets Inc., Barclays Capital Inc. and Scotia Capital (USA) Inc., as the representatives of the underwriters named therein (the “Underwriters”), and Wells Fargo Securities, LLC, Citigroup Global Markets Inc., Barclays Capital Inc. and Scotia Capital (USA) Inc. as forward sellers (the “Forward Sellers”), pursuant to which the Forward Sellers sold to the Underwriters an aggregate of 19,247,788 shares of Common Stock.
Filing page
SEC filing
FFAI
Faraday Future pauses 400V Super One, upgrades to 800V BEV or AIHER hybrid; robotics shipments reach 68 units
FARADAY FUTURE INTELLIGENT ELECTRIC INC.
May 7, 2026, 7:59 PM ET
other_material
Items 1.01, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 8.01, 9.01
same event type: other_material
similar materiality
This filing
026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,
Comparable filing
On April 30, 2026, GlobeX AI Hong Kong Holding Limited (“GlobeX”), a special purpose entity controlled by Faraday Future Intelligent Electric Inc. (the “Company”), entered into a Supplemental Agreement (the “Supplemental Agreement”) to the previously executed Engineering Services Agreement, dated February 4, 2026, with its previously announced bridge strategy partner (the Partner”),
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.